Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.
about
Antidepressant medication use during breastfeedingPredicting plasma concentrations of bisphenol A in children younger than 2 years of age after typical feeding schedules, using a physiologically based toxicokinetic modelDrug-induced renal damage in preterm neonates: state of the art and methods for early detectionStrategic biomarkers for drug development in treating rare diseases and diseases in neonates and infantsMechanisms of lead and manganese neurotoxicityApproaches for assessing risks to sensitive populations: lessons learned from evaluating risks in the pediatric populationLife cycle analysis of kidney gene expression in male F344 ratsDevelopmental expression and function of aldehyde reductase in proximal tubules of the kidneyPopulation pharmacokinetics of tamsulosin hydrochloride in paediatric patients with neuropathic and non-neuropathic bladderPopulation pharmacokinetics of amphotericin B lipid complex in neonates.Ethanol pharmacokinetics in neonates and infantsPharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy.Developmental and pediatric pharmacogenomics.Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations.Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs.Modelling approaches to dose estimation in childrenDevelopmental changes rather than repeated administration drive paracetamol glucuronidation in neonates and infants.A bodyweight-dependent allometric exponent for scaling clearance across the human life-span.Clinical Pharmacology Studies in Critically Ill Children.Computational pharmacokinetics during developmental windows of susceptibility.Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenSummary of the National Institute of Child Health and Human Development-best pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop-Pediatric Biopharmaceutics Classification System Working Group.Non-nutritive sweeteners in breast milk: perspective on potential implications of recent findings.Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtrationFrom pediatric covariate model to semiphysiological function for maturation: part I-extrapolation of a covariate model from morphine to Zidovudine.Developmental pharmacology: neonates are not just small adults...Pharmacogenetics in clinical pediatrics: challenges and strategies.Drug Development for Pediatric Populations: Regulatory Aspects.Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity.Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment.Propofol and children--what we know and what we do not know.Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model?Prediction of drug clearance in children 3 months and younger: an allometric approach.My child is unique; the pharmacokinetics are universal.A review of the use of latanoprost for glaucoma since its launch.Neonatal pharmacology: extensive interindividual variability despite limited size.Allometric extrapolation of factors VII, VIII and IX clearance in children from adults.Physiologically based pharmacokinetic (PBPK) modeling in children.Prediction of morphine clearance in the paediatric population : how accurate are the available pharmacokinetic models?
P2860
Q24611422-519C3A13-FBE7-4E51-9B83-C09D5806C1A9Q24647832-D1CB2A5E-B62B-4988-AA2B-E1D158BB7A0CQ26849339-B8EBC3A2-5816-4E37-B71E-81A796C4C91DQ27024346-8480C2A7-D144-41CA-B3CD-E8311EEFD7EEQ28388379-CC1D94C1-7424-4E65-A3A1-BC648A6C46E3Q28389663-91488CEA-864A-44CD-B033-5D95B9C9BF97Q28534148-86ECE19C-49BA-4200-9C89-5C646D8E7831Q28588454-8EAD31D7-ACA8-49FC-9017-2FE6B9736462Q34019358-DC47CF39-9E5F-4211-85C7-45A0B3E2BD30Q34228332-BA1C95ED-0EBE-4106-BC5A-368E0F6475D8Q34440525-A8CBFEA6-DC11-403D-A42D-3B4130E32DF4Q34737758-168A7A29-A6B1-4C24-AB04-FCA78AE76678Q35116112-9099F7BB-E5D4-4DF6-AB91-461C56FED5CEQ35598492-D712CDD1-2735-434D-BA00-9C6A21937FECQ35827012-DEB9ADDF-7AF8-40B5-AAB7-8ECAA722028FQ35827045-F44E4B38-72ED-45BD-AAD3-D7303D1274BBQ35941220-DB48F1B0-CB9B-4C0D-AE4B-B7CB9F5C3556Q35949142-88061D32-740C-48E5-9FE4-6868613F5538Q36120465-B51DC7DB-FAD9-48AA-9455-1603A86B464CQ36195215-63359433-8297-489C-B774-5C538556E41BQ36322918-8DDDDF55-91C2-46E3-AFFF-789CB01190D2Q36501845-90DA36C3-9438-48D3-A465-3260138B4C16Q36568181-97942E7D-73BB-4AFA-88AD-182115CE187DQ36568925-978E3FE9-697C-424A-A638-E7E167FCD2D0Q36702365-B5E02C95-E8DF-41A9-A82D-B8CB487D1B29Q37127683-D3426875-6A68-4234-98C2-B1492A18C48FQ37400384-25C2698C-EDD8-44CF-9B48-C88639C0A46BQ37666706-969C7E9B-C1BE-4E86-906C-548142FDF5D9Q37695055-9FD203B8-57F8-4981-8C11-82E8878E3F46Q37698407-4F3705E1-2FDD-4F21-BBA5-0C481D6931EDQ37775981-A94E2F58-9EAC-4935-8BD0-AF37C155379AQ37810340-6C76CABF-26B4-4B2E-AF22-5A9CCD9F3181Q37818515-20556562-D3B6-4674-97D5-FEF56B3BB0F5Q37854677-3F0994DD-40C3-4662-8F34-17CA2691D0D9Q37973872-A84FD822-3BCF-4992-BBDA-BEAB1C670638Q37986149-417BD832-AAB9-45BF-90C2-6A19B1778725Q38000252-55F611EB-3DAB-45CA-B9FA-714A824642E9Q38011809-49FEB98B-A694-43C8-BE89-59AFC99E11D0Q38016332-101CE087-60A2-4A7E-8847-733199B3F3E7Q38047202-528B9C9B-CB0B-4BD0-8E17-4375B5CC7F2B
P2860
Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.
@ast
Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.
@en
Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.
@nl
type
label
Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.
@ast
Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.
@en
Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.
@nl
prefLabel
Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.
@ast
Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.
@en
Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.
@nl
P1476
Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.
@en
P2093
Jane Alcorn
Patrick J McNamara
P304
P356
10.2165/00003088-200241120-00003
P577
2002-01-01T00:00:00Z
P6179
1004419281